Pharvaris Netherlands B.v.

This study is testing a long-term, daily oral tablet called deucrictibant to see if it can safely prevent the sudden, severe swelling attacks caused by hereditary angioedema (HAE). It will involve about 170 adolescents and adults with HAE who will take the pill once a day for ove…

This study is testing a new oral medication called deucrictibant for adults with a rare condition called acquired angioedema, which causes sudden, severe swelling. The trial has two main goals: to see if a daily pill can prevent attacks from happening, and to see if a fast-acting…